Li Kang Biomedical Co Ltd

6242 · TWO · Consumer Cyclical / Travel Services

31.20TWD-0.80 (-2.50%)

Price History

Full chart

Market Stats

Previous Close32.00

Open31.10

Day Range31.10 – 31.55

52-Week Range33.60 – 39.23

Volume19.23K

Market Cap1.08B

P/E (TTM)14.16

Forward P/E0.00

EPS2.39

Dividend Yield5.91%

Beta-0.10

50-Day Avg34.17

200-Day Avg36.93

About

Li Kang Biomedical Co., Ltd. produces and sells pharmaceuticals, beauty products, and health food. It offers Chinese and Western medicines, nutritional supplements, beauty and skincare products, and daily necessities products. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd. in September 2014. Li Kang Biomedical Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.

Company Details

SectorConsumer Cyclical
IndustryTravel Services
CEOYu-Xiu Zheng
Employees0
HeadquartersNo. 29, Huangong Road, Tainan City, Taiwan, 710, Taiwan
Websitehttps://www.likangbio.com

Leadership

Yu-Xiu ZhengChairman & Manager
Li Yu LinAccounting Supervisor

Financials

Income Statement

Currency: TWD	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: TWD	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	941.25M	998.33M	949.76M	949.50M	886.65M	704.51M	505.56M	334.73M	228.71M	168.08M	246.87M	237.35M	255.93M	455.81M	450.61M	495.94M	495.57M	483.30M	456.72M	386.97M	684.25M	629.38M	565.51M	589.21M
Growth (%)	-	+6.06%	-4.86%	-0.03%	-6.62%	-20.54%	-28.24%	-33.79%	-31.67%	-26.51%	+46.87%	-3.86%	+7.83%	+78.10%	-1.14%	+10.06%	-0.08%	-2.48%	-5.50%	-15.27%	+76.82%	-8.02%	-10.15%	+4.19%
Cost of Revenue	698.47M	774.21M	770.71M	760.68M	672.73M	538.17M	384.96M	251.69M	191.11M	121.50M	176.79M	190.32M	120.14M	148.87M	147.03M	157.85M	156.13M	150.25M	156.09M	122.29M	295.68M	203.23M	179.42M	190.96M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	306.94M	303.58M	338.09M	339.44M	333.05M	300.63M	264.68M	388.58M	426.14M	386.10M	398.25M
Gross Margin	-	-	-	-	-	-	-	-	-	-	-	-	-	67.34%	67.37%	68.17%	68.50%	68.91%	65.82%	68.40%	56.79%	67.71%	68.27%	67.59%
Operating Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	253.94M	236.99M	253.36M	248.44M	244.74M	213.15M	200.75M	247.49M	286.38M	296.08M	299.97M
Operating Income	21.07M	-	-	-	-	-	-	-	-	-	-	-	7.03M	52.99M	66.59M	84.73M	91.00M	88.31M	87.49M	63.94M	141.09M	139.76M	90.02M	98.28M
Operating Margin	2.24%	-	-	-	-	-	-	-	-	-	-	-	2.75%	11.63%	14.78%	17.09%	18.36%	18.27%	19.16%	16.52%	20.62%	22.21%	15.92%	16.68%
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	156.62M	115.48M	109.88M	102.51M	76.83M	152.07M	151.51M	112.31M	113.22M
EBITDA Margin	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	31.58%	23.30%	22.74%	22.44%	19.85%	22.22%	24.07%	19.86%	19.21%
Net Income	19.46M	-	-	-	-	-	-	-	-	-	-	-	-	52.85M	61.51M	133.74M	76.74M	72.02M	69.27M	51.44M	112.09M	110.99M	77.02M	83.82M
Net Income Margin	2.07%	-	-	-	-	-	-	-	-	-	-	-	-	11.60%	13.65%	26.97%	15.48%	14.90%	15.17%	13.29%	16.38%	17.64%	13.62%	14.23%
R&D	-	-	-	-	-	-	-	-	-	-	18.09M	14.26M	4.26M	761.00K	505.00K	90.00K	18.00K	3.00K	0	0	-	-	-	-
R&D as % of Total Revenue	-	-	-	-	-	-	-	-	-	-	7.33%	6.01%	1.66%	0.17%	0.11%	0.02%	0.00%	0.00%	0.00%	0.00%	-	-	-	-
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	924.00K	779.00K	546.00K	455.00K	290.00K	618.00K	693.00K	372.00K
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.19%	0.16%	0.12%	0.12%	0.04%	0.10%	0.12%	0.06%

Balance Sheet

Currency: TWD	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: TWD	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	765.96M	770.15M	766.35M	791.11M	757.63M	701.86M	438.89M	252.83M	153.96M	182.81M	147.57M	111.79M	324.37M	526.73M	554.77M	596.06M	609.85M	626.44M	644.77M	616.07M	688.84M	827.00M	1.04B	1.09B
Total Liabilities	418.31M	432.09M	442.91M	567.66M	541.69M	290.32M	247.58M	124.35M	49.65M	59.37M	62.45M	87.50M	96.93M	246.44M	213.96M	150.38M	142.93M	143.00M	136.46M	124.07M	118.70M	196.97M	179.93M	221.82M
Total Equity	347.64M	338.06M	323.44M	223.45M	215.94M	411.54M	191.32M	128.49M	104.31M	123.43M	85.12M	24.29M	227.44M	280.29M	340.80M	445.68M	466.92M	483.44M	508.30M	492.00M	570.14M	630.03M	855.68M	871.24M
Cash	32.32M	56.30M	47.22M	101.91M	56.27M	137.17M	27.94M	11.34M	46.58M	70.40M	25.39M	12.49M	256.08M	83.60M	149.88M	204.34M	164.61M	142.10M	98.10M	101.36M	132.01M	111.84M	64.95M	42.92M
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	55.09M	41.34M	18.55M	101.44M	-	-
Net Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-43.01M	-60.02M	-113.46M	-10.40M	-	49.44M

Cash Flow

Currency: TWD	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: TWD	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	45.87M	5.63M	-	-	-	-	-	28.97M	-	-	-	-	41.66M	63.91M	110.82M	110.61M	105.53M	92.56M	81.67M	60.45M	157.24M	96.74M	65.38M	92.15M
Investing Cash Flow	-	-	-	-	143.22M	146.21M	-	3.41M	14.13M	-	-	-	1.59M	-374.39M	-1.67M	-2.58M	-76.41M	-50.68M	-73.07M	12.20M	-59.62M	-	-	-
Financing Cash Flow	-	35.66M	50.60M	111.61M	-	-	33.88M	-	63.60M	74.25M	1.53M	9.52M	200.09M	138.00M	-42.87M	-53.57M	-68.86M	-64.38M	-52.60M	-69.39M	-66.97M	-55.07M	-	-
Capital Expenditure	102.38M	18.50M	19.02M	38.19M	827.00K	59.18M	11.54M	6.35M	354.00K	4.40M	4.45M	280.00K	7.61M	375.25M	4.44M	2.98M	77.35M	153.00K	1.88M	4.45M	2.70M	3.26M	64.73M	329.54M
Free Cash Flow	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	107.17M	28.09M	92.41M	79.79M	56.00M	154.54M	93.48M	654.00K	-237.40M
Dividends Paid	27.00M	-	-	-	-	-	-	-	-	-	-	-	-	1.00M	1.00M	28.86M	55.50M	55.50M	44.40M	62.16M	33.30M	46.62M	79.52M	63.61M
FCF to OCF	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	96.89%	26.62%	99.83%	97.70%	92.64%	98.28%	96.63%	1.00%	-257.63%
Dividend Paid to FCF	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	26.93%	197.59%	60.06%	55.65%	111.01%	21.55%	49.87%	12158.56%	-26.80%

Key Statistics & Ratios

Market Cap1.08B

Enterprise Value1.06B

Trailing P/E14.16

Forward P/E0.00

Price / Sales1.88

Price / Book1.28

EPS2.39

Book Value26.50

Revenue (TTM)573.36M

Gross Profit (TTM)385.44M

EBITDA94.30M

Profit Margin13.32%

Operating Margin16.70%

Return on Equity9.12%

Return on Assets4.84%

Shares Outstanding31.81M

Shares Float12.61M

Beta-0.10

Dividend Yield5.91%

Dividend Rate2.00

Payout Ratio83.80%

Dividends

20261×

2.00Jun 16, 2026

20251×

2.00Jun 16, 2025

20241×

2.50Jun 20, 2024

20231×

1.93Jun 30, 2023

20221×

1.26Jul 4, 2022

20211×

2.24Sep 2, 2021

20201×

1.60Jun 30, 2020

20191×

2.00Jun 25, 2019

20181×

2.00Jun 20, 2018

20171×

1.04Jul 7, 2017

20161×

0.04Aug 31, 2016

Stock Splits

Jun 30, 20231150:1000
Jul 4, 20221050:1000
Aug 31, 20161110:1000
Mar 28, 20140.2678:1
Apr 8, 20090.6058:1